Physician profile
John A Morrison
NPI 1457342263
$12,721.30
in general payments reported to CMS, 2019-2025
46 companies · $3,995 in 2025
The $3,995 reported for 2025 was more than what 80% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,008 · 2020: $454 · 2021: $1,705 · 2022: $1,712 · 2023: $1,834 · 2024: $2,013 · 2025: $3,995.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,429 · Travel and Lodging: $2,412.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,429.26 |
| Travel and Lodging | $2,412.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,908.18 | 2021-2025 | Corevalve Evolut R, Symplicity G3, Onyx Frontier |
| Abiomed | $1,459.81 | 2020-2025 | Impella |
| Boston Scientific Corporation | $1,338.19 | 2019-2024 | Versacross Access Solution, Watchman Flx, Watchman Access System |
| Pfizer INC. | $870.36 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $724.33 | 2019-2025 | Camzyos, Eliquis |
| Edwards Lifesciences Corporation | $498.13 | 2023-2025 | Sapien 3 Ultra Resilia |
| Shockwave Medical, INC | $459.93 | 2021-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Novartis Pharmaceuticals Corporation | $421.40 | 2019-2025 | |
| Amgen INC. | $410.66 | 2019-2025 | Repatha, Repatha |
| Abbott Laboratories | $374.47 | 2019-2025 | Cardiomems, Aveir, Amplatzer Talisman |
| Intuitive Surgical, INC. | $364.84 | 2022 | |
| Janssen Pharmaceuticals, INC | $358.52 | 2019-2023 | Xarelto |
| Terumo Medical Corporation | $228.47 | 2021-2025 | Metacross Otw, Glidewire |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $227.86 | 2019-2025 | Lifevest |
| Cvrx, INC. | $210.47 | 2024-2025 | Barostim Neo System |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Morrison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.